However, since the aforementioned studies are retrospective and differ in composition of the examined cohorts of patients as well as in the study design, we felt that further studies in a more homogeneous cohort of breast cancer patients were needed to investigate the impact of COX-2 expression on prognosis. Here, PTGS2 is linked to breast cancer.